Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?
Laurén
J
J
Molecular/Cancer Biology Laboratory, Haartman Institute, University of Helsinki, Finland.
Gunji
Y
Y
Alitalo
K
K
D042683:Angiopoietin-1; D042702:Angiopoietin-2; D000818:Animals; D005909:Glioblastoma / Q000098:blood supply*; D006801:Humans; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D051379:Mice; D009389:Neovascularization, Pathologic / Q000235:genetics; D014176:Protein Biosynthesis; D011506:Proteins / Q000235:genetics / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology; D042787:Receptor, TIE-2; D011956:Receptors, Cell Surface / Q000502:physiology; D042764:Receptors, TIE
D042683:Angiopoietin-1; D042702:Angiopoietin-2; C467628:Angpt1 protein, mouse; D008562:Membrane Glycoproteins; D011506:Proteins; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D020794:Receptor Protein-Tyrosine Kinases; D042787:Receptor, TIE-2; D042764:Receptors, TIE